Cancer News - Page 256

Patient characteristics influence readmissions after colorectal surgery

- When patients wind up back in the hospital in the months following surgery, it may reflect more than just the quality of the hospital, a recent study suggests.

Juno says 2 more patients die in leukemia drug trial

Juno Therapeutics is halting the study of an experimental leukemia treatment for a second time after the death of two more patients.

86-year-old man battling cancer knits 300 hats for premature babies

An 86-year-old man battling cancer has managed to knit 300 caps for premature babies, which he says is his way of “paying it forward.”

Palliative care linked to better, if not longer, life

- Palliative care may offer a better quality of life to chronically sick or terminally ill patients even if it doesn't help them live longer, a research review suggests.

FDA outlines data needed for over-the-counter sunscreen additives

The U.S. Food and Drug Administration issued guidelines on Tuesday detailing the data makers of sunscreen sold over the counter need to produce to prove the ingredients in the products are safe and effective.

Former President HW Bush shares new pic with cancer survivor

Former president's heartwarming reunion

George H.W. Bush shares new photo of boy he shaved head for

Three years after shaving his head to show support for a toddler battling leukemia, Former President George H.W. Bush says that same boy "is feeling and doing much better."

IVF leaves baby at lower risk of breast cancer despite family history

Meet little Noah – the first named baby born free of the “Angelina Jolie” cancer gene thanks to a groundbreaking IVF treatment.

Parents of children with cancer see income dips and loss of employment

Even accounting for social and economic status, having a child with cancer is tied to income reductions for parents and job discontinuation for mothers, according to a new study.

FDA lifts hold on AstraZeneca head and neck cancer trials

U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding.